- Issuer
- Janus Henderson
- Inception Date
- Dec 31, 1998
- Category
- Health & Biotech Equities
- Index Tracked
- No Index (Active)
- Distribution Policy
- Distributing
- Asset Class
- Equity
- Asset Class Size
- Large-Cap
- Asset Class Style
- Growth
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
JAGLX Performance Chart
Janus Henderson Global Life Sciences Fund Class T (JAGLX) is up 0.5% since the beginning of the year. JAGLX is currently trading at $81 per share. Investors who bought $1,000 worth of JAGLX shares 5 years ago would now be looking at an investment worth $1,475.
Loading charts...
Returns By Period
Janus Henderson Global Life Sciences Fund Class T (JAGLX) has returned 0.53% so far this year and 31.08% over the past 12 months. Over the last ten years, JAGLX has returned 11.69% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Janus Henderson Global Life Sciences Fund Class T
- 1D
- -0.39%
- 1M
- 0.72%
- YTD
- 0.53%
- 6M
- 0.00%
- 1Y
- 31.08%
- 3Y*
- 11.89%
- 5Y*
- 8.09%
- 10Y*
- 11.69%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
JAGLX Monthly Returns History
Based on dividend-adjusted daily data since Dec 31, 1998, JAGLX's average daily return is +0.05%, while the average monthly return is +1.06%. At this rate, an investment would double in approximately 5.5 years.
Historically, 63% of months were positive and 37% were negative. The best month was Feb 2000 with a return of +40.8%, while the worst month was Mar 2000 at -29.5%. The longest winning streak lasted 15 consecutive months, and the longest losing streak was 6 months.
On a daily basis, JAGLX closed higher 53% of trading days. The best single day was Oct 13, 2008 with a return of +11.7%, while the worst single day was Mar 16, 2020 at -10.4%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.77% | 2.05% | -6.41% | 1.81% | 2.42% | 0.17% | 0.53% | ||||||
| 2025 | 5.93% | -0.22% | -4.46% | -0.31% | -5.70% | 2.33% | -0.87% | 6.13% | 2.87% | 8.70% | 9.27% | -0.12% | 24.72% |
| 2024 | 2.75% | 3.84% | 1.72% | -4.65% | 3.56% | 3.20% | 2.66% | 5.17% | -2.41% | -3.30% | -0.71% | -3.01% | 8.50% |
| 2023 | 0.48% | -4.33% | 2.68% | 4.02% | -2.32% | 2.98% | 1.01% | -1.39% | -3.75% | -6.12% | 7.42% | 7.57% | 7.41% |
| 2022 | -9.06% | 0.57% | 3.59% | -6.71% | -0.92% | -0.78% | 3.66% | -2.55% | -2.88% | 8.53% | 6.01% | -0.89% | -2.79% |
| 2021 | -0.84% | 0.07% | -1.93% | 3.11% | 0.25% | 3.57% | 0.15% | 3.19% | -4.08% | 4.49% | -7.40% | 6.75% | 6.66% |
Benchmark Metrics
Janus Henderson Global Life Sciences Fund Class T has an annualized alpha of 6.46%, beta of 0.77, and R2 of 0.57 versus S&P 500 Index. Calculated based on daily prices since December 31, 1998.
- This fund participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (85.57%) than losses (64.06%) - typical of diversified or defensive assets.
- This fund generated an annualized alpha of 6.46% versus S&P 500 Index - delivering returns beyond what market exposure alone would predict.
- Alpha
- 6.46%
- Beta
- 0.77
- R²
- 0.57
- Upside Capture
- 85.57%
- Downside Capture
- 64.06%
Expense Ratio
JAGLX has an expense ratio of 0.92%, placing it in the medium range.
Return for Risk
Risk / Return Rank
JAGLX ranks 59 for risk / return — on par with similar mutual funds. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Janus Henderson Global Life Sciences Fund Class T (JAGLX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| JAGLX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | 0.00 | ||
| Sortino ratioReturn per unit of downside risk | +0.22 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.37 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | 3.17 | 2.78 | +0.39 |
| Martin ratioReturn relative to average drawdown | 10.08 | 12.44 | -2.36 |
Dividends
Dividend History
Janus Henderson Global Life Sciences Fund Class T provided a 4.50% dividend yield over the last twelve months, with an annual payout of $3.64 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $3.64 | $3.64 | $7.41 | $2.90 | $0.09 | $6.73 | $5.50 | $3.77 | $6.72 | $0.48 | $0.51 | $4.74 |
Dividend yield | 4.50% | 4.53% | 10.98% | 4.22% | 0.14% | 9.78% | 7.75% | 6.17% | 13.38% | 0.89% | 1.13% | 9.09% |
Monthly Dividends
The table displays the monthly dividend distributions for Janus Henderson Global Life Sciences Fund Class T. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.64 | $3.64 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $7.41 | $7.41 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.90 | $2.90 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.09 | $0.09 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $6.73 | $6.73 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Janus Henderson Global Life Sciences Fund Class T. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Janus Henderson Global Life Sciences Fund Class T was 58.96%, occurring on Feb 13, 2003. Recovery took 2290 trading sessions.
The current Janus Henderson Global Life Sciences Fund Class T drawdown is 2.48%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2003 bear market2003 | -58.96%Feb 2003 | 2y 11mo | 9y 1mo | 12y 16dMar 2000 - Mar 2012 |
2016 bear market2016 | -30.84%Feb 2016 | 6mo 22d | 1y 11mo | 2y 6moJul 2015 - Jan 2018 |
COVID crash2020 | -27.38%Mar 2020 | 1mo 2d | 2mo 11d | 3mo 13dFeb 2020 - Jun 2020 |
Bear market2022 | -22.25%Jun 2022 | 7mo 14d | 1y 6mo | 2y 1moNov 2021 - Dec 2023 |
Rate-hike selloffLate 2018 | -18.68%Dec 2018 | 2mo 24d | 3mo 12d | 6mo 6dOct 2018 - Apr 2019 |
Drawdown Indicators
| JAGLX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.96% | -56.78% | -2.18% |
Max Drawdown (1Y)Largest decline over 1 year | -9.71% | -9.10% | -0.61% |
Max Drawdown (3Y)Largest decline over 3 years | -17.41% | -18.90% | +1.49% |
Max Drawdown (5Y)Largest decline over 5 years | -22.25% | -25.43% | +3.18% |
Max Drawdown (10Y)Largest decline over 10 years | -27.38% | -33.92% | +6.54% |
Current DrawdownCurrent decline from peak | -2.48% | -1.80% | -0.68% |
Average DrawdownAverage peak-to-trough decline | -17.40% | -10.71% | -6.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.05% | 2.03% | +1.02% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with JAGLX
Add Janus Henderson Global Life Sciences Fund Class T to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with JAGLX